Antitumor agent-102
Antitumor Agent-102 is a novel SN38 conjugate that incorporates a glucose transporter inhibitor, designed for targeted colorectal cancer research. It demonstrates superior tumor tissue accumulation and release of the active topoisomerase I inhibitor SN38 compared to irinotecan in preclinical models, supporting investigations into combination therapeutic strategies.
Product Specifications
Field of Research
Metabolism Research, Molecular Biology
Molecular Formula
C70H82N8O18S
Molecular Weight
1355.51
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog